Connect with us

business

Details Unveiled on Cannabis Rescheduling Recommendation

Published

on


Summary: Recently unsealed documents reveal the U.S. Department of Health and Human Services (HHS) recommended cannabis rescheduling from Schedule I to Schedule III under the Controlled Substances Act. This change, based on accepted medical use and lower abuse potential, could significantly impact marijuana research and industry regulations.

A Turning Point in Drug Policy: HHS Recommends Cannabis Rescheduling

The unsealing of documents from the HHS has brought to light a significant recommendation regarding the reclassification of marijuana. The HHS has proposed moving marijuana from Schedule I to Schedule III under the Controlled Substances Act, acknowledging its accepted medical use and lower potential for abuse compared to Schedule I substances. This recommendation, if implemented, could lead to substantial changes in how marijuana is researched, prescribed, and regulated.

Currently, marijuana’s Schedule I status, shared with drugs like heroin and LSD, indicates no accepted medical use and a high potential for abuse. This classification has long been a point of contention, given the growing body of research and state-level legalizations acknowledging marijuana’s medical benefits. The proposed reclassification to Schedule III, which includes drugs like anabolic steroids and Tylenol with codeine, recognizes marijuana’s medical utility and lower abuse risk.

The HHS’s recommendation aligns with the FDA’s evaluation, which also supports marijuana’s medical use. This development follows a series of steps taken by federal agencies and legislators to reevaluate marijuana’s legal status and potential benefits. The DEA has been urged to consider these recommendations and reschedule marijuana accordingly.

The implications of this reclassification are far-reaching. It could ease restrictions on marijuana research, allowing for more comprehensive studies on its medical applications and effects. It could also lead to changes in banking regulations and tax laws affecting the marijuana industry, potentially fostering growth and innovation.

Why It Matters: The HHS’s recommendation to reclassify marijuana as a Schedule III substance is a pivotal moment in the ongoing debate over marijuana’s legal status and medical use. This change could revolutionize marijuana research and the industry, potentially leading to new medical treatments and economic opportunities.

Potential Implications: If marijuana is reclassified to Schedule III, it could open doors for more extensive research, leading to new medical discoveries and treatments. It could also reshape the marijuana industry, with changes in banking, taxation, and regulation, potentially boosting economic growth and innovation.

Source: MJBizDaily


Subscribe to our weekly newsletter:

We hope you enjoyed this news update. Check back with us daily to see what’s going on in the world of cannabis and psychedelics. And make sure to subscribe to our weekly newsletter, the Cannadelics Sunday Edition with a the best stories of the week:

.

.

AI Disclaimer: This news update was created using a AI tools. PsychePen is an AI author who is constantly improving. We appreciate your kindness and understanding as PsychePen continues to learn and develop. Please note that the provided information is derived from various sources and should not be considered as legal, financial, or medical advice.



Source link

Continue Reading

business

Green Dragon dispensaries, grow facility to remain open after cash infusion

Published

on

By



In an unexpected turn, Green Dragon, one of the largest dispensary chains in Colorado, will keep its stores and grow facility open.

The retailer’s parent company, California-based Eaze, got an infusion of $10 million from its owner, Jim Clark, to remain operating, it announced Tuesday. Clark, the billionaire founder of the defunct tech firm Netscape, foreclosed on the company’s assets in August for $54 million.

“We’ve just been working with the new ownership group to assess what we’re doing in the future,” said Cory Azzalino, Eaze’s CEO. “It’s nothing world-shaking, but I’m excited to keep going.”

Read the rest of this story on DenverPost.com.



Source link

Continue Reading

business

Green Dragon founders fired up to “get back to where we were” with new joint

Published

on

By



The first dispensary chain founded by Alex Levine, Andy Levine and Lisa Leder is preparing to cease operations in Colorado, three years after they sold it.

But they have high expectations for take two — their new chain, Fired Cannabis.

“Our plan is to get back to where we were,” said Alex Levine. “It’s just a long detour.”

Read the rest of this story on DenverPost.com.



Source link

Continue Reading

business

384 flights canceled at DIA as heavy snow pelts metro Denver

Published

on

By



At least 384 flights were canceled and 467 delayed at Denver International Airport on Friday as heavy snow pelted metro Denver and Colorado’s eastern plains.

The Federal Aviation Administration activated a traffic management program for flights bound for DIA “due to weather/snow-ice.” The average delay for flights under this plane was one hour and 50 minutes, FAA officials said, adding that departing flight schedules also may be affected by the weather.

There were 851 total delayed and canceled flights at DIA as of 11:45 a.m., according to Flight Aware. SkyWest reported the most cancellations with 183, followed by Southwest with 124, and Frontier with 30.

Read the rest of this story on TheKnow.DenverPost.com.



Source link

Continue Reading
Advertisement

Trending

Copyright © 2021 The Art of MaryJane Media